Issue 1/2021
Content (11 Articles)
Short-term effects of a Paleolithic lifestyle intervention in breast cancer patients undergoing radiotherapy: a pilot and feasibility study
Rainer J. Klement, Petra S. Koebrunner, Kelley Krage, Michael M. Weigel, Reinhart A. Sweeney
LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway
Junhe Li, Wei Huang, Qing Han, Jianping Xiong, Zhiwang Song
Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma
Sahar K. Hegazy, Sahar M. El-Haggar, Suzan A. Alhassanin, Eman I. El-berri
Integration of gene expression data identifies key genes and pathways in colorectal cancer
Hossein Hozhabri, Ali Lashkari, Seyed-Morteza Razavi, Ali Mohammadian
Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy
Kazuma Fujita, Satoru Motoyama, Yusuke Sato, Akiyuki Wakita, Yushi Nagaki, Yoshihiro Minamiya, Masatomo Miura
Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor
Nehad M. Ayoub, Amer E. Alkhalifa, Dalia R. Ibrahim, Ahmed Alhusban
Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways
Tânia Lima, Rui Henrique, Rui Vitorino, Margarida Fardilha
The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer
Emir Celik, Nilay Sengul Samanci, Mehmet Karadag, Nebi Serkan Demirci, Fuat Hulusi Demirelli, Mustafa Ozguroglu
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review
Priyanka Singh, Veerandra Kumar, Sonu Kumar Gupta, Gudia Kumari, Malkhey Verma
Saying goodbye to primary endocrine resistance for advanced breast cancer?
Cengiz Karacin, Yakup Ergun, Omur Berna Oksuzoglu